These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8265611)

  • 1. Pulse mass measles vaccination across age cohorts.
    Agur Z; Cojocaru L; Mazor G; Anderson RM; Danon YL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11698-702. PubMed ID: 8265611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy.
    Tulchinsky TH; Abed Y; Ginsberg G; Shaheen S; Friedman JB; Schoenbaum ML; Slater PE
    Rev Infect Dis; 1990; 12(5):951-8. PubMed ID: 2237137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
    Anderson RM; May RM
    J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles immunization strategies for an epidemiologically heterogeneous population: the Israeli case study.
    Agur Z; Danon YL; Anderson RM; Cojocaru L; May RM
    Proc Biol Sci; 1993 May; 252(1334):81-4. PubMed ID: 8391705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C; Mankertz A
    Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles antibody in the children in Ubon Ratchathani province.
    Saipan P; Jiwapaisarnpong T; Pattanadilok S; Loyha Y; Janggajit T
    J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles containment in Israel.
    Slater PE
    Isr J Med Sci; 1991 Jan; 27(1):19-21. PubMed ID: 1995495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1991 measles epidemic in Israel.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1992-1993; 20(1-2):41-51. PubMed ID: 1305976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of measles in Israel: implications of a long-term partial immunization program.
    Swartz TA
    Public Health Rep; 1984; 99(3):272-7. PubMed ID: 6429725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a measles elimination strategy on measles incidence in Malaysia.
    Saraswathy TS; Zahrin HN; Norhashmimi H; Az-Ulhusna A; Zainah S; Rohani J
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):742-7. PubMed ID: 19842408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age.
    Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of measles in Israel: short- and long-term intervention strategies.
    Tulchinsky TH
    Isr J Med Sci; 1991 Jan; 27(1):22-9. PubMed ID: 1995496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.